ES8201166A1 - Un procedimiento para preparar un solvato solido del acido sin-7-(2-(2-amino-4-tiazolil)-2-metoximino)-acetamido-3-acetoximetil-3-cefem-4-carboxilico - Google Patents

Un procedimiento para preparar un solvato solido del acido sin-7-(2-(2-amino-4-tiazolil)-2-metoximino)-acetamido-3-acetoximetil-3-cefem-4-carboxilico

Info

Publication number
ES8201166A1
ES8201166A1 ES495753A ES495753A ES8201166A1 ES 8201166 A1 ES8201166 A1 ES 8201166A1 ES 495753 A ES495753 A ES 495753A ES 495753 A ES495753 A ES 495753A ES 8201166 A1 ES8201166 A1 ES 8201166A1
Authority
ES
Spain
Prior art keywords
preparation
cephalosporin derivatives
cephem
methoxyimino
acetoxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES495753A
Other languages
English (en)
Other versions
ES495753A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8201166A1 publication Critical patent/ES8201166A1/es
Publication of ES495753A0 publication Critical patent/ES495753A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN SOLVATO SOLIDO DEL ACIDO SIN-7-(2-AMINO-4/TIAZOLIL)-2-METAXIIMINO)-ACETAMIDO-3-ACETOXIMETIL-3-CEFEM-4-CARBOXILICO. CONSISTE EN COMBINAR, EN UN MEDIO ACUOSO, ACIDO CEFEM CON UN ETER ALICICLICO, COMO TERRAHIDROFURANO; 1,4-DIOXANO, 1,3-DIOXOLANO O TERRAHIDROPIRANO. SE AJUSTA EL PH DE LA MEZCLA A UN VALOR COMPRENDIDO ENTRE 2,2 Y 3,5, Y SE DEJA QUE LA MISMA REPOSE, A TEMPERATURA AMBIENTE, HASTA QUE SE FORME UN PRECIPITADO DE SOLVATO, QUE SE AISLA. A PARTIR DE ESTE MOMENTO PUEDE VIEN SEPARARSE EL ETER DEL SOLVATO,PARA PRODUCIR EL ACIDO LIBRE, O BIEN HACERLO REACCIONAR CON UNA BASE PARA OBTENER UNA SAL DE ACIDO. DE APLICACION COMO COMPUESTOS INTERMEDIO EN LA ELABORACION DE SALES PARA PRODUCIR ANTIBIOTICOS.
ES495753A 1979-10-09 1980-10-08 Un procedimiento para preparar un solvato solido del acido sin-7-(2-(2-amino-4-tiazolil)-2-metoximino)-acetamido-3-acetoximetil-3-cefem-4-carboxilico Granted ES495753A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/082,822 US4252951A (en) 1979-10-09 1979-10-09 Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid

Publications (2)

Publication Number Publication Date
ES8201166A1 true ES8201166A1 (es) 1981-12-01
ES495753A0 ES495753A0 (es) 1981-12-01

Family

ID=22173679

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495753A Granted ES495753A0 (es) 1979-10-09 1980-10-08 Un procedimiento para preparar un solvato solido del acido sin-7-(2-(2-amino-4-tiazolil)-2-metoximino)-acetamido-3-acetoximetil-3-cefem-4-carboxilico

Country Status (27)

Country Link
US (1) US4252951A (es)
EP (1) EP0027050B1 (es)
JP (1) JPS5661388A (es)
KR (1) KR840000866B1 (es)
AT (1) AT369008B (es)
AU (1) AU6306180A (es)
BE (1) BE885569A (es)
CA (1) CA1146539A (es)
CH (1) CH647523A5 (es)
CS (1) CS215142B2 (es)
DD (1) DD153375A5 (es)
DE (1) DE3065181D1 (es)
DK (1) DK424680A (es)
ES (1) ES495753A0 (es)
FI (1) FI803200L (es)
FR (1) FR2467211A1 (es)
GB (1) GB2059966B (es)
GR (1) GR70219B (es)
HU (1) HU183230B (es)
IE (1) IE50390B1 (es)
IL (1) IL61227A (es)
IT (1) IT1132926B (es)
PH (1) PH15023A (es)
PT (1) PT71886B (es)
RO (1) RO80664B (es)
YU (1) YU256480A (es)
ZA (1) ZA806192B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588086A (ja) * 1981-07-07 1983-01-18 Takeda Chem Ind Ltd セフアロスポリン溶媒和物およびその製造法
JPH07116200B2 (ja) * 1985-09-20 1995-12-13 富山化学工業株式会社 セファロスポリンの製造方法
JPH08831B2 (ja) * 1985-09-20 1996-01-10 富山化学工業株式会社 セファロスポリンの精製法
DE60039132D1 (de) * 1999-04-06 2008-07-17 Sepracor Inc O-Desmethylvenlafaxin-Succinat
ATE504572T1 (de) * 1999-09-02 2011-04-15 Shionogi & Co Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
CA2284459C (en) * 1999-10-04 2012-12-11 Neokimia Inc. Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
EP1246792B1 (en) * 2000-01-13 2014-08-13 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ATE510547T1 (de) * 2001-03-08 2011-06-15 Univ Pennsylvania Faciale amphiphile polymere als infektionsbekämpfende mittel
NZ531139A (en) * 2001-08-29 2007-09-28 Neose Technologies Inc Synthetic ganglioside derivatives and compositions thereof
CA2498944C (en) * 2002-09-19 2011-05-17 Yasushi Kohno Amino alcohol derivatives, salts thereof and immunosuppressive agents
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
JP2006521355A (ja) * 2003-03-17 2006-09-21 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア・センター・フオー・テクノロジー・トランスフアー 表面的に両親媒性のポリマー及びオリゴマーならびにそれらの使用
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US20050203184A1 (en) 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
CN1922133A (zh) * 2004-01-23 2007-02-28 宾夕法尼亚州大学理事会 表面两亲性聚芳基和聚芳基炔基聚合物和低聚物及其用途
US7825278B2 (en) * 2004-05-06 2010-11-02 The Regents Of The University Of California Substituted enaminones, their derivatives and uses thereof
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
JP2008531585A (ja) * 2005-02-25 2008-08-14 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 表面が両親媒性のポリマーおよびオリゴマー、それらの組成物そして癌治療方法におけるそれらの使用
CN101166706B (zh) * 2005-02-28 2011-08-24 明治乳业株式会社 氢醌长链衍生物和/或苯氧基长链衍生物及含有它们的药品
AU2006279943B2 (en) * 2005-08-10 2012-02-16 The Johns Hopkins University Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
JP5270343B2 (ja) * 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
US8592433B2 (en) * 2005-10-28 2013-11-26 Advait Nagle Compounds and compositions as protein kinase inhibitors
EP1954259A2 (en) * 2005-11-29 2008-08-13 Hammersmith Imanet, Ltd Amidine derivatives for in vivo imaging
ES2288107B1 (es) * 2006-01-27 2008-11-01 Fundacion Imabis Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanita Derivados aciclicos saturados e insaturados de cadena larga de sulfamidas como activadores especificos de receptores ppar-alfa.
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
US20090075935A1 (en) * 2006-07-03 2009-03-19 L'oreal Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use
FR2902999B1 (fr) * 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
ES2375761T3 (es) * 2006-12-14 2012-03-06 Teva Pharmaceutical Industries Ltd. Base de rasagilina cristalina sólida.
CN101730706B (zh) * 2007-05-11 2015-04-15 生物科技研究有限公司 具有神经保护和增强记忆活性的受体拮抗剂
US7696383B2 (en) * 2007-06-26 2010-04-13 Solvay Pharmaceuticals B.V. N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
FR2920000B1 (fr) * 2007-08-13 2010-01-29 Oreal Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement
US8252935B2 (en) * 2007-10-19 2012-08-28 Janssen Pharmaceutica N.V. Piperidinyl and piperazinyl modulators of γ-secretase
WO2009052334A1 (en) * 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
AU2008312371B2 (en) * 2007-10-19 2013-06-20 Janssen Pharmaceutica, N.V. Amine linked modulators of gamma-secretase
EP2093207A1 (en) * 2008-02-06 2009-08-26 Julius-Maximilians-Universität Würzburg Antiinfective and antitumoral compounds isolated from tropical lianas
US8063249B1 (en) * 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
US20100056475A1 (en) * 2008-08-06 2010-03-04 Alexander Chucholowski Cyclodextrin conjugates
JP5773877B2 (ja) * 2008-10-22 2015-09-02 アキュセラ インコーポレイテッド 眼の疾患及び障害を治療する化合物
FR2940610B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
US9187482B2 (en) * 2009-05-14 2015-11-17 Millennium Pharmaceuticals, Inc. Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
WO2010138828A2 (en) * 2009-05-29 2010-12-02 Abbott Laboratories Potassium channel modulators
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
WO2012067824A1 (en) 2010-11-16 2012-05-24 Abbott Laboratories Potassium channel modulators
CN108272782B (zh) * 2011-09-06 2021-04-23 库尔纳公司 小分子在制备治疗Dravet综合征或全面性癫痫伴热性惊厥附加症的药物中的用途
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid

Also Published As

Publication number Publication date
JPS5661388A (en) 1981-05-26
KR840000866B1 (ko) 1984-06-20
RO80664A (ro) 1983-02-15
IL61227A (en) 1983-07-31
PT71886B (en) 1981-08-13
EP0027050A1 (en) 1981-04-15
EP0027050B1 (en) 1983-10-05
IE50390B1 (en) 1986-04-16
DK424680A (da) 1981-04-10
PH15023A (en) 1982-05-13
CS215142B2 (en) 1982-07-30
IT8025200A0 (it) 1980-10-08
DE3065181D1 (en) 1983-11-10
GB2059966A (en) 1981-04-29
KR830004314A (ko) 1983-07-09
ATA498080A (de) 1982-04-15
HU183230B (en) 1984-04-28
AT369008B (de) 1982-11-25
ES495753A0 (es) 1981-12-01
FI803200L (fi) 1981-04-10
FR2467211B1 (es) 1983-06-10
BE885569A (fr) 1981-04-08
CA1146539A (en) 1983-05-17
IL61227A0 (en) 1980-12-31
GR70219B (es) 1982-08-31
IE802086L (en) 1981-04-09
GB2059966B (en) 1983-09-01
DD153375A5 (de) 1982-01-06
AU6306180A (en) 1981-04-16
IT1132926B (it) 1986-07-09
CH647523A5 (fr) 1985-01-31
YU256480A (en) 1983-02-28
PT71886A (en) 1980-11-01
RO80664B (ro) 1983-02-28
FR2467211A1 (fr) 1981-04-17
US4252951A (en) 1981-02-24
ZA806192B (en) 1982-05-26

Similar Documents

Publication Publication Date Title
ES8201166A1 (es) Un procedimiento para preparar un solvato solido del acido sin-7-(2-(2-amino-4-tiazolil)-2-metoximino)-acetamido-3-acetoximetil-3-cefem-4-carboxilico
IL62506A0 (en) Production of certain cephalosporin derivatives,novel intermediates for use therein and their production
JPS5334794A (en) Cephalosporin derivatives and their preparation
ES8304143A1 (es) "procedimiento para la preparacion de derivados de cefem".
NO803470L (no) Fremgangsmaate for fremstilling av 7-acylamino-3-vinylcefalosporansyrederivater.
NO161495C (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenyl)acetamido))-gruppeholdige cefalosporansyrederivater.
ES8200695A1 (es) Procedimiento para la preparacion de cefalosporinas cromofo-ras
IE782546L (en) Amino-thiazolyl cephalosporins
ES480990A1 (es) Un procedimiento para la preparacion de derivados acilados.
AU520450B2 (en) Oxime derivatives of 7-aminothiazolyl acetamido cephalosporanic acid
ZA802393B (en) Heterocyclyl derivatives of oxy-imino-substituted cephalosporins
ES476154A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina
JPS5642596A (en) Production of cephalosporin by fermentation
IL49318A (en) 3-amimo-substituted cephalosporins their preparation and their use for the preparation of 3h 3-alkyl and 3-phenyl-3-cephem antibiotic compounds
ES442057A1 (es) Procedimiento para la obtencion de penicilinas.
EP0047014A3 (en) Novel thioesters and process for the preparation of the same, and process for the preparation of cephalosporin derivatives using the novel thioesters
AU512859B2 (en) Ethers of clavulanic acid
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
ES480762A1 (es) Procedimiento para la preparacion de derivados de cefem.
GB2040942B (en) Derivatives of cephalosporin c
ES8306746A1 (es) Un procedimiento para la preparacion de 1h- o 2h-tetrazol-5-tiol
ES464764A1 (es) Un procedimiento para preparar un compuesto de indol-dihi- droindoldionadimerico
AU538175B2 (en) Preparation of penicillins or cephalosporins
ES457370A1 (es) Procedimiento de preparacion de nuevos derivados del nafta- leno.
FR2418800A1 (fr) Nouvelles cephalosporines et leur procede de preparation